<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="brief-report"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Cell Death Discov</journal-id><journal-id journal-id-type="iso-abbrev">Cell Death Discov</journal-id><journal-title-group><journal-title>Cell Death Discovery</journal-title></journal-title-group><issn pub-type="epub">2058-7716</issn><publisher><publisher-name>Nature Publishing Group UK</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7248455</article-id><article-id pub-id-type="publisher-id">276</article-id><article-id pub-id-type="doi">10.1038/s41420-020-0276-1</article-id><article-categories><subj-group subj-group-type="heading"><subject>Comment</subject></subj-group></article-categories><title-group><article-title>ACE2 expression and sex disparity in COVID-19</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Gagliardi</surname><given-names>Maria Cristina</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3635-7664</contrib-id><name><surname>Tieri</surname><given-names>Paolo</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9845-8105</contrib-id><name><surname>Ortona</surname><given-names>Elena</given-names></name><address><email>elena.ortona@iss.it</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Ruggieri</surname><given-names>Anna</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9120 6856</institution-id><institution-id institution-id-type="GRID">grid.416651.1</institution-id><institution>Center for Gender Specific Medicine, </institution><institution>Istituto Superiore di Sanit&#x000e0;, </institution></institution-wrap>Rome, Italy </aff><aff id="Aff2"><label>2</label>CNR National Research Council, IAC Institute for Applied Computing, Rome, Italy </aff></contrib-group><pub-date pub-type="epub"><day>26</day><month>5</month><year>2020</year></pub-date><pub-date pub-type="pmc-release"><day>26</day><month>5</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>6</volume><elocation-id>37</elocation-id><history><date date-type="received"><day>4</day><month>5</month><year>2020</year></date><date date-type="accepted"><day>12</day><month>5</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2020</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article&#x02019;s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x02019;s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2020</meta-value></custom-meta></custom-meta-group></article-meta></front><body><p id="Par1">Coronavirus disease 2019 (COVID-19) death rate differs depending on sex: in Chinese confirmed cases, while the infection rate among men and women is similar, the death rate among men is 4.7% compared with 2.8% for women<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>. Italian data are similar as the reported death rate in men is significantly higher than that in women, 16.6% vs. 9.1%, respectively. Moreover, preliminary data from Italian epidemics suggest also a significant sex difference in infection rate, being 52.5% in women and 47.5% in men (Integrated Surveillance on COVID19 epidemic in Italy published by Italian Institute of Health, April 28th 2020, <ext-link ext-link-type="uri" xlink:href="https://www.epicentro.iss.it/coronavirus/bollettino/Bollettino-sorveglianza-integrata-COVID-19_28-aprile_2020.pdf">https://www.epicentro.iss.it/coronavirus/bollettino/Bollettino-sorveglianza-integrata-COVID-19_28-aprile_2020.pdf</ext-link>).</p><p id="Par2">So far, the mechanisms underlying the observed gender bias are not disclosed; however, some hypotheses can be put forward on the basis of current knowledge on gender differences in respiratory viral diseases.</p><p id="Par3">The sex different lifestyles, such as smoking addiction that is prevalent in men than in women, is considered one of the potential risk factor for developing pneumonia consequent to COVID-19<sup><xref ref-type="bibr" rid="CR2">2</xref></sup>. In addition, it is known that, in general, innate and immune responses are more intense and stronger in females than in males<sup><xref ref-type="bibr" rid="CR3">3</xref></sup>. This can provide women with a more effective weapon to fight new and infective pathogens, favouring viral clearance.</p><p id="Par4">However, further factors could be taken into account in order to explain the sex bias in COVID-19 death rates. In particular, the human angiotensin-converting enzyme 2 (ACE2), an essential enzyme of the renin&#x02013;angiotensin system (RAS), is the functional receptor for the severe acute respiratory syndrome coronavirus (SARS-CoV) as well as for the recently identified SARS-CoV-2<sup><xref ref-type="bibr" rid="CR4">4</xref>,<xref ref-type="bibr" rid="CR5">5</xref></sup>. It has been shown that ACE2 plays a protective role in chronic pathologies, like hypertension, cardiovascular diseases, and acute respiratory distress syndrome, that are the comorbidities representing the risk of worse prognosis in COVID-19. The protective role of ACE2 has been evidenced by studies in mice models, showing more severe lung failure upon ACE2 down-regulation<sup><xref ref-type="bibr" rid="CR6">6</xref></sup>.</p><p id="Par5">Intriguingly, infection with SARS-CoV induces ACE2 down-regulation through binding of the viral Spike protein to ACE2, thus reducing ACE2 expression in the lung and igniting acute respiratory failure<sup><xref ref-type="bibr" rid="CR6">6</xref></sup>. Since COVID-19 and SARS patients share similar acute respiratory distress syndrome and a similar gender bias in disease susceptibility and case fatality rates, it is reasonable to believe that they share similar pathogenic mechanisms<sup><xref ref-type="bibr" rid="CR7">7</xref></sup>.</p><p id="Par6">Estrogen, the primary female sex hormone, has been observed to play a protective role in SARS not only by activating immune response but also suppressing directly SARS-CoV replication<sup><xref ref-type="bibr" rid="CR8">8</xref></sup>. To note, estrogen inhibits the activity or expression of different components of the renin&#x02013;angiotensin system. In particular, estrogen is able to upregulate the expression of ACE2<sup><xref ref-type="bibr" rid="CR9">9</xref></sup>.</p><p id="Par7">Furthermore, the gene encoding ACE2 is located on the X chromosome, in sites commonly escaping the inactivation of one X chromosome in mammalian XX cells (XCI), a mechanism that determine the X chromosome transcriptional silencing and avoids redundant gene expression in female cells. However, the silencing is not complete but about 10% of the genes escape the inactivation; as a consequence XX cells over-express genes located in XCI sites, like ACE2<sup><xref ref-type="bibr" rid="CR10">10</xref></sup>.</p><p id="Par8">Consequently, hormonal and genetic factors could lead to ACE2 over-expression in female sex. These insights could, at least partially, account for the better outcome and the lower death rate in female SARS-CoV-2 patients with respect to males. All in all, further studies appear as mandatory to evaluate: (i) whether women who use hormone replacement therapy (HRT) are better protected from respiratory failure than women who do not use HRT; (ii) whether estrogenic agonists, increasing ACE2 expression levels, could represent promising tools to fight the COVID-19 outbreak. Notwithstanding, the study of the role of XCI escaping genes, and of their regulators, could represent a major challenge to understand the sex-specific pathogenic determinants of COVID-19 disease progression.</p></body><back><fn-group><fn><p>Edited by A. Rufini</p></fn><fn><p><bold>Publisher&#x02019;s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><notes id="FPar1" notes-type="COI-statement"><title>Conflict of interest</title><p id="Par9">The authors declare that they have no conflict of interest.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team.</collab></person-group><article-title>The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19)</article-title><source>China CDC Wkly.</source><year>2020</year><volume>2</volume><fpage>113</fpage><lpage>122</lpage></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vardavas</surname><given-names>CI</given-names></name><name><surname>Nikitara</surname><given-names>K</given-names></name></person-group><article-title>COVID-19 and smoking: a systematic review of the evidence</article-title><source>Tob. Induc. Dis.</source><year>2020</year><volume>18</volume><fpage>20</fpage><pub-id pub-id-type="doi">10.18332/tid/119324</pub-id><pub-id pub-id-type="pmid">32206052</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghosh</surname><given-names>S</given-names></name><name><surname>Klein</surname><given-names>RS</given-names></name></person-group><article-title>Sex drives dimorphic immune responses to viral infections</article-title><source>J. Immunol.</source><year>2017</year><volume>198</volume><fpage>1782</fpage><lpage>1790</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1601166</pub-id><pub-id pub-id-type="pmid">28223406</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wan</surname><given-names>Y</given-names></name><name><surname>Shang</surname><given-names>J</given-names></name><name><surname>Graham</surname><given-names>R</given-names></name><name><surname>Baric</surname><given-names>RS</given-names></name><name><surname>Li</surname><given-names>F</given-names></name></person-group><article-title>Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS</article-title><source>J. Virol.</source><year>2020</year><volume>94</volume><fpage>e00127-20</fpage><pub-id pub-id-type="doi">10.1128/JVI.00127-20</pub-id><pub-id pub-id-type="pmid">31996437</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuba</surname><given-names>K</given-names></name><etal/></person-group><article-title>A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lunginjury</article-title><source>Nat. Med.</source><year>2005</year><volume>11</volume><fpage>875</fpage><lpage>879</lpage><pub-id pub-id-type="doi">10.1038/nm1267</pub-id><pub-id pub-id-type="pmid">16007097</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><mixed-citation publication-type="other">Hanff, T. C., Harhay, M. O., Brown, T. S., Cohen, J. B. &#x00026; Mohareb, A. M. Is there an association between COVID-19 mortality and the renin-angiotensin system&#x02014;a call for epidemiologic investigations. <italic>Clin. Infect. Dis</italic>. 10.1093/cid/ciaa329 (2020).</mixed-citation></ref><ref id="CR7"><label>7.</label><mixed-citation publication-type="other">Cheng, H., Wang, Y. &#x00026; Wang G. Q. Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19. <italic>J. Med. Virol</italic>. 10.1002/jmv.25785 (2020).</mixed-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Channappanavar</surname><given-names>R</given-names></name><name><surname>Fett</surname><given-names>C</given-names></name><name><surname>Mack</surname><given-names>M</given-names></name><name><surname>Ten Eyck</surname><given-names>PP</given-names></name><name><surname>Meyerholz</surname><given-names>DK</given-names></name><name><surname>Perlman</surname><given-names>S</given-names></name></person-group><article-title>Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection</article-title><source>J. Immunol.</source><year>2017</year><volume>198</volume><fpage>4046</fpage><lpage>4053</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1601896</pub-id><pub-id pub-id-type="pmid">28373583</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bukowska</surname><given-names>A</given-names></name><etal/></person-group><article-title>Protective regulation of theACE2/ACE gene expression by estrogen in human atrial tissue from elderly men</article-title><source>Exp. Biol. Med. (Maywood)</source><year>2017</year><volume>242</volume><fpage>1412</fpage><lpage>1423</lpage><pub-id pub-id-type="doi">10.1177/1535370217718808</pub-id><pub-id pub-id-type="pmid">28661206</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tukiainen</surname><given-names>T</given-names></name><etal/></person-group><article-title>Landscape of X chromosome inactivation across human tissues</article-title><source>Nature</source><year>2017</year><volume>550</volume><fpage>244</fpage><lpage>248</lpage><pub-id pub-id-type="doi">10.1038/nature24265</pub-id><pub-id pub-id-type="pmid">29022598</pub-id></element-citation></ref></ref-list></back></article>